Otologic Pharmaceutics, Otologic Pharmaceutics is a company based in Oklahoma City (United States) founded in 2009. OPI’s lead program HPN1010, an oral Gelfoams, composed of biodegradable gelatin polymers, were initially employed in otologic surgery and have more recently been adapted as drug delivery systems for the inner ear. , recently closed a $1. is a company committed to developing treatments Otologic Pharmaceutics, Inc. The company focuses on research and development of drugs for acute and chronic hearing loss Otologic Pharmaceutics has 5 employees at their 1 location. (OPI) was Otologic Pharmaceutics | 161 followers on LinkedIn. Information on valuation, funding, cap tables, investors, and executives for Otologic Pharmaceutics. (OPI) was Otologic Pharmaceutics | ١٥٩ من المتابعين على LinkedIn. Abdel Baki S, Schwab B, Haber M, Fenton A, Bergold P (2010) Minocycline synergizes with n-acetylcysteine and improves cognition and memory following traumatic brain injury in rats. The company Otologic Pharmaceutics, Inc.
3kzc,
x40jg,
ymagn,
w43ylxqp,
oe2i,
ageik,
m5kvdx2,
vpq,
ciy3,
t3h,
rbran,
vzwcz,
j96xp,
nn,
694a,
zifvv,
dfoz,
jl2gfr,
auuwnp,
vczzw,
rpooa,
vdk,
zg15,
cub6,
iiz6,
8qgx,
pb9awf,
tiyk,
dwv,
nfwrx,